Neuroprotection in stroke by complement inhibition and immunoglobulin therapy

This publication has 177 references indexed in Scilit:

• Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death
  Proceedings of the National Academy of Sciences, 2007
• New perspectives on mannan-binding lectin-mediated complement activation
  Immunobiology, 2007
• Reduced Tissue Damage and Improved Recovery of Motor Function after Traumatic Brain Injury in Mice Deficient in Complement Component C4
  Journal of Cerebral Blood Flow & Metabolism, 2007
• The Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand Binding
  Journal of Biological Chemistry, 2007
• The antiinflammatory activity of IgG: the intravenous IgG paradox
  The Journal of Experimental Medicine, 2007
• Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors
  Proceedings of the National Academy of Sciences, 2006
• Expression of complement regulators and receptors on human NT2-N neurons—Effect of hypoxia and reoxygenation
  Molecular Immunology, 2006
• Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson’s disease
  Biochemical and Biophysical Research Communications, 2006
• The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats
  Neuroscience Letters, 2005
• Antigen‐specific immunotherapy for autoimmune disease: fighting fire with fire?
  Immunology, 2001